ReferIndia News Prism Johnson Board Approves Fund Raising of Up to ₹500 Crores via Equity Securities and ₹1,250 Crores via NCDs

ReferIndia News

ePrescribe

Upgrade your clinic to smart, simple, and paperless management—start today!

Know more
News Image

Prism Johnson Board Approves Fund Raising of Up to ₹500 Crores via Equity Securities and ₹1,250 Crores via NCDs

Published on: May 14, 2026, 3:43 p.m. | Source: scanx.trade

Prism Johnson Limited's Board of Directors, at its meeting on May 14, 2026, approved raising up to ₹500 Crores through equity shares and equity-linked instruments via various permissible modes, and up to ₹1,250 Crores through Secured/Unsecured Redeemable Non-convertible Debentures on a private placement basis. Both proposals are subject to shareholder approval at the ensuing Annual General Meeting and applicable statutory and regulatory approvals. The specific mode of issuance for equity securities and detailed terms for NCDs will be determined by the Board of Directors or the Fund Raising Committee at the relevant time.

Checkout more news
Ad Banner

✅ Secure, cloud-based clinic management software

Manage digital prescriptions, appointments, patient records, billing, files, and reports — everything your clinic needs in one powerful platform.

Know more
ReferIndia News contact